India Levofloxacin Market to grow at a steady rate During the Forecast Period
Growing adoption of Levofloxacin
for treating bacterial infections is expected to drive the growth of India
levofloxacin market during the forecast period.
According
to TechSci Research report, “India Levofloxacin Market By Strength (250 mg
Tablets, 500 mg Tablets, 750 mg Tablets), By Application (Pneumonia, Skin
Infection, Kidney Infection, Bladder Infection, Others), By Form (Tablet,
Capsule, Injection), By Route of Administration (Oral v/s Intravenous), By
Source (In-house v/s Contract Manufacturing Organizations), By Distribution
Channel (Online v/s Offline), By End User (Adult v/s Paediatric), By Company, By
Region, Forecast & Opportunities, FY2026”, the India Levofloxacin market is expected to grow at a
steady pace during the forecast period owing to rise in the cases of bacterial
infectious diseases. Continuous research in applications of levofloxacin by
major market players coupled with involvement of international organizations is
another major factor which is expected to fuel the market growth through
FY2026. Levofloxacin is primarily used in skin infections as it is indicated
for the treatment of complicated skin and skin structure infections caused by Enterococcus
faecalis, methicillin-susceptible Staphylococcus aureus (MRSA), Streptococcus
pyogenes, or Proteus mirabilis and others. However, side effects caused due to
drug consumption including nausea, seizures, and diarrhea can restrict the
market growth over the next few years. lack of awareness associated with
infectious disease among the population might act as a major impediment to the
market growth in the coming years.
Browse
XX market data Tables and XX Figures spread through XXX Pages and an in-depth TOC
on "
India Levofloxacin
Market"
https://www.techsciresearch.com/report/india-levofloxacin-market/7199.html
The India levofloxacin market is segmented based on strength, application, form, route of
administration, source, distribution channel, end user, company, and
region. Based on application, the market can be categorized into pneumonia,
skin infection, kidney infection, bladder infection, other. The pneumonia segment
dominated the market until FY2020 and is forecasted to maintain its lead over
the coming years as well. Rising incidence of pneumococcal disease is a high
impact rendering driver. Furthermore, there has been a considerable increase in
the number of community-acquired and ventilator-associated bacterial pneumonia,
which is further estimated to boost the segmental growth. Based on end user,
the market can be fragmented into adult v/s pediatric. Adult end user segment
dominated the market until FY2020 and is expected to maintain its dominance in
the market during forecasted years as well on account of high incidence of
bacterial infections in adults.
Dr. Reddy’s Laboratories Ltd., Aden
Healthcare Pvt. Ltd., Allenge India Pharmaceuticals Pvt. Ltd., Alna Biotech
Pvt. Ltd., Bestochem Formulations India Ltd., Glenmark Pharmaceuticals Ltd., Lupin
Ltd., Cadila Healthcare Ltd., Valentis Pharma Pvt. Ltd., Pax Healthcare Pvt. Ltd. and
others are some of the leading players operating in India levofloxacin market. Companies operating in the market are using organic
strategies such as product launches, mergers and acquisitions and research collaborations
to boost their share and increase their geographic reach.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7199
Customers can also request for 10% free customization on
this report.
“India levofloxacin market is expected to
witness growth in the next 5 years which can be attributed to the use of this
drug for the diagnosis of pneumonia, urinary tract infection, acute bacterial
sinusitis, chronic prostatitis, and others. In addition to this, increased count
of skin and bacterial infections among the population is further expected to
create lucrative opportunities for the market growth of India levofloxacin market
over the next five years. Emergence of multi-drug resistant pathogens is further
forecasted to aid the growth of levofloxacin market over the forthcoming years.” said Mr. Karan Chechi, Research Director with
TechSci Research, a research based India management consulting firm.
“India Levofloxacin Market By Strength (250 mg
Tablets, 500 mg Tablets, 750 mg Tablets), By Application (Pneumonia, Skin
Infection, Kidney Infection, Bladder Infection, Others), By Form (Tablet,
Capsule, Injection), By Route of Administration (Oral v/s Intravenous), By
Source (In-house v/s Contract Manufacturing Organizations), By Distribution
Channel (Online v/s Offline), By End User (Adult v/s Paediatric), By Company, By
Region, Forecast & Opportunities, FY2026”, has evaluated the future growth potential of India levofloxacin
market and provides statistics & information on market size, structure and
future market growth. The report intends to provide cutting-edge market
intelligence and help decision makers take sound investment decisions. Besides,
the report also identifies and analyzes the emerging trends along with
essential drivers, challenges and opportunities in India levofloxacin market.
Contact
Mr. Ken Mathews
708
Third Avenue,
Manhattan,
NY,
New
York – 10017
Tel:
+1-646-360-1656
Email:
[email protected]